Long-Term Activation of Group I Metabotropic Glutamate Receptors Increases Functional TRPV1- Expressing Neurons in Mouse Dorsal Root Ganglia

Takayoshi Masuoka1*, Makiko Kudo1, Junko Yoshida1, Takaharu Ishibashi1,2, Ikunobu Muramatsu1, Nobuo Kato3, Noriko Imaizumi1 and Matomo Nishio1
1 Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Japan, 2 Department
of Pharmacology, School of Nursing, Kanazawa Medical University, Uchinada, Japan, 3 Department of Physiology I, School of Medicine, Kanazawa Medical University, Uchinada, Japan

fncel-10-00079

Damaged tissues release glutamate and other chemical mediators for several hours. These chemical mediators contribute to modulation of pruritus and pain. Herein, we investigated the effects of long-term activation of excitatory glutamate receptors on functional expression of transient receptor potential vaniloid type 1 (TRPV1) in dorsal root ganglion (DRG) neurons and then on thermal pain behavior. In order to detect the TRPV1-mediated responses in cultured DRG neurons, we monitored intracellular calcium responses to capsaicin, a TRPV1 agonist, with Fura-2. Long-term (4 h) treatment with glutamate receptor agonists (glutamate, quisqualate or DHPG) increased the proportion of neurons responding to capsaicin through activation of metabotropic glutamate receptor mGluR1, and only partially through the activation of mGluR5; engagement of these receptors was evident in neurons responding to allylisothiocyanate (AITC), a transient receptor potential ankyrin type 1 (TRPA1) agonist. Increase in the proportion was suppressed by phospholipase C (PLC), protein kinase C, mitogen/extracellular signal-regulated kinase, p38 mitogen-activated protein kinase or transcription inhibitors. Whole-cell recording was performed to record TRPV1-mediated membrane current; TRPV1 current density significantly increased in the AITC-sensitive neurons after the quisqualate treatment. To elucidate the physiological significance of this phenomenon, a hot plate test was performed. Intraplantar injection of quisqualate or DHPG induced heat hyperalgesia that lasted for 4 h post injection. This chronic hyperalgesia was attenuated by treatment with either mGluR1 or mGluR5 antagonists. These results suggest that long-term activation of mGluR1/5 by peripherally released glutamate may increase the number of neurons expressing functional TRPV1 in DRG, which may be strongly associated with chronic hyperalgesia.
Keywords: metabotropic glutamate receptors, TRPV1, TRPA1, dorsal root ganglion, heat hyperalgesia

A Cell-Based Functional Assay Using a Green Fluorescent Protein-Based Calcium Indicator dCys-GCaMP
Bin Cai,1 Xia Chen,1 Fang Liu,1 Jun Li,1 Lijuan Gu,2 Jason R. Liu,3 and Jay Liu1
1Rugen Therapeutics Ltd., Suzhou Industrial Park, China. 2Biotech Development Co., Ltd., Suzhou Industrial Park, China. 3Summer Intern from Penn State University, University Park, Pennsylvania.

adt%2E2014%2E584

Measurement of the changes in intracellular Ca2+ levels is an important assay for drug discovery. In this report, we describe a novel Ca2+ indicator, dCys-GCaMP, based on the green fluorescent protein and the development of a rapid and simple cell-based functional assay using this new Ca2+ indicator. We demonstrated the sensitivity and reliability of the assay by measuring the cellular responses to the agonists, antagonists, channel blockers, and modulators of the ionotropic N-methyl-D-aspartate (NMDA) subtype of glutamate receptors. HEK293 cells coexpressing the NMDA receptor and dCys-GCaMP displayed a strong increase in fluorescence intensity when stimulated with the agonist glutamate. This increase in the fluorescence signal was agonist concentration dependent and could be blocked by NMDAR antagonists and channel blockers. The pharmacological parameters measured with the dCys-GCaMP assay are in close agreement with those derived from conventional assays with synthetic dye fluo-4 and literature values. In addition, we showed that this assay could be used on G protein-coupled receptors as well, as exemplified by studies on the a1A adrenergic receptor. A limited scale evaluation of the assay performance in a 96-well compound screening format suggests that the dCys-GCaMP assay could be easily adapted to a high-throughput screening environ- ment. The most important advantage of this new assay over the con- ventional fluo-4 and aequorin assays is the elimination of the dye-loading or substrate-loading process.

Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists
Kerstin Hill,*,† Serena Fiorito,‡ Vito Alessandro Taddeo,‡ Anja Schulze,§ Marion Leonhardt,† Francesco Epifano,*,‡ and Salvatore Genovese‡
†Rudolf-Boehm-InstitutfürPharmakologieundToxikologie,UniversitaẗLeipzig,Har̈telstr.16-18,04107Leipzig,Germany ‡Department of Pharmacy, University “G. D’Annunzio” of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy §Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Biozentrum, Weinbergweg 22, 06120 Halle, Germany

Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists

ABSTRACT: A series of seven oxyprenylated phenylpropanoids and naphthoquinones were tested regarding their ability to activate transient receptor potential ankyrin subtype 1 channel (TRPA1). Three of the assayed compounds, namely, boropinal (3), juglone (5), and plumbagin (7), acted as strong modulators of TRPA1 channels with EC50 values of 9.8, 1.7,and 0.5 μM, respectively, as assessed by Ca2+ assays. Moreover, the compounds elicited TRPA1 currents in electrophysiological whole cell recordings. We additionally provide evidence that plumbagin activated TRPA1-positive neurons isolated from mouse dorsal root ganglion neurons but did not affect sensory neurons from TRPA1-deficient mice. The high potencies of plumbagin and juglone to activate TRPA1 channels may explain the molecular basis of the mucosal irritant properties of these compounds as well as of related naphthoquinones and phytopreparations, as widely reported in the literature.

GROWTH FACTORS, CYTOKINES, AND CELL CYCLE MOLECULES
Histamine Released from Epidermal Keratinocytes Plays a Role in a-MelanocyteeStimulating Hormone-Induced Itching in Mice

Histamine Released from Epidermal Keratinocytes Plays a Role in a-MelanocyteeStimulating Hormone-Induced Itching in Mice

Kyoko Shimizu,* Tsugunobu Andoh,y Yoko Yoshihisa,* and Tadamichi Shimizu*
From the Departments of Dermatology* and Applied Pharmacology,y Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

Sunburn, wound repair, and chronic renal failure with hemodialysis are usually accompanied by both pigmentation and itching. Proopiomelanocortin-derived a-melanocyteestimulating hormone (a-MSH) is produced in response to external stimuli, such as UV irradiation, and is involved in cutaneous pigmen- tation. However, it is unclear whether a-MSH is also involved in the itching. We therefore investigated whether a-MSH elicited itch-related responses in mice. We found that an intradermal injection of a-MSH induced hind-paw scratching, an itch-related response, in mice. The a-MSHeinduced scratching was inhibited by the m-opioid receptor antagonist naltrexone and the H1 histamine receptor antagonist terfenadine. In mast cell-deficient mice, a-MSH also elicited scratching, which was inhibited by terfe- nadine. The immunoreactivity for L-histidine decarboxylase, a key enzyme required for the production of histamine, histamine, and the melanocortin 1 and 5 receptors were shown in not only mast cells but also keratinocytes in murine skin. In addition to the expression of L-histidine decarboxylase and melanocortin 1 and 5 receptors, the mouse keratinocyte cell lines (Pam212) also showed immunoreactivity for L-histidine decarboxylase, histamine, and melanocortin 1 and 5 receptors. The application of a-MSH induced the release of histamine from Pam212 cells. These findings indicate that a-MSH may play an important role in the itching associated with pigmented cutaneous lesions and that the histamine released from keratinocytes is involved in this a-MSHeinduced itching. (Am J Pathol 2015, 185: 3003e3010; http://dx.doi.org/10.1016/j.ajpath.2015.07.015)

Toll-like receptor 4 contributes to chronic itch, alloknesis and spinal astrocyte activation in male mice
Tong Liu , Qingjian Han , Gang Chen , Ya Huang , Lin-Xia Zhao , Temugin Berta ,Yong-Jing Gao , and Ru-Rong Ji

Running title: TLR4 and glial signaling in acute and chronic itch

00006396-900000000-99651

Abstract
Increasing evidence suggests that Toll-like receptor 4 (TLR4) contributes importantly to spinal cord glial activation and chronic pain sensitization; however, its unique role in acute and chronic itch is unclear. In this study, we investigated the involvement of TLR4 in acute and chronic itch models in male mice using both transgenic and pharmacological approaches. Tlr4−/− mice exhibited normal acute itch induced by compound 48/80 and chloroquine, but these mice showed substantial reductions in scratching in chronic itch models of dry skin, induced by acetone and diethyether followed by water (AEW), contact dermatitis, and allergic contact dermatitis on the neck. Intrathecal (spinal) inhibition of TLR4 with lipopolysaccharide Rhodobacter sphaeroides (LPS-RS) did not affect acute itch but suppressed AEW-induced chronic itch. Compound 48/80 and AEW also produced robust alloknesis, a touch-elicited itch in wild-type mice, which was suppressed by intrathecal LPS-RS and Tlr4−/− deletion. AEW induced persistent upregulation of Tlr4 mRNA and increased TLR4 expression in GFAP-expressing astrocytes in spinal cord dorsal horn. AEW also induced TLR4-dependent astrogliosis (GFAP upregulation) in spinal cord. Intrathecal injection of astroglial inhibitor L-α- aminoadipate reduced AEW-induced chronic itch and alloknesis without affecting acute itch. Spinal TLR4 was also necessary for AEW-induced chronic itch in the cheek model. Interestingly, scratching plays an essential role in spinal astrogliosis, since AEW-induced astrogliosis was abrogated by putting Elizabethan Collars on the neck to prevent scratching the itchy skin. Our findings suggest that spinal TLR4 signaling is important for spinal astrocyte activation and astrogliosis that may underlie alloknesis and chronic itch.
Key words: Alloknesis (touch-evoked itch), astrogliosis, dry skin, innate immunity, lipopolysaccharide (LPS), Toll-like receptor 4 (TLR4)

Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus

1-s2.0-S0016508510007377-main

ANDREAS E. KREMER,* JOB J. W. W. MARTENS,* WIM KULIK,‡ FRANZISKA RUËFF,§ EDITH M. M. KUIPER,? HENK R. VAN BUUREN,? KAREL J. VAN ERPECUM,¶ JURATE KONDRACKIENE,# JESUS PRIETO,** CHRISTIAN RUST,‡‡ VICTORIA L. GEENES,§§ CATHERINE WILLIAMSON,§§ WOUTER H. MOOLENAAR,?? ULRICH BEUERS,* and RONALD P. J. OUDE ELFERINK* *Tytgat Institute for Liver and Intestinal Research and ‡Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; §Departments of Dermatology and Allergology, University of Munich, Munich, Germany; ‡‡Internal Medicine II – Grosshadern, University of Munich, Munich, Germany; ?Department of Gastroenterology & Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands; ¶Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, The Netherlands; #Department of Gastroenterology, Kaunas University of Medicine, Kaunas, Lithuania; **Department of Medicine and Liver Unit, Clinica Universitaria, Medical School and Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; §§Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, England; and ?Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

BACKGROUND & AIMS: Pruritus is a common and disabling symptom in cholestatic disorders. However, its causes remain unknown. We hypothesized that potential pruritogens accumulate in the circulation of cholestatic patients and activate sensory neurons.
METHODS: Cytosolic free calcium ([Ca2?]i) was measured in neuronal cell lines by ratiometric fluorometry upon exposure to serum samples from pruritic patients with intrahepatic cholestasis of pregnancy (ICP), primary biliary cirrhosis (PBC), other cholestatic disorders, and pregnant, healthy, and nonpruritic disease controls. Putative [Ca2?]i-induc- ing factors in pruritic serum were explored by analytical techniques, including quantification by high-performance liquid chromatography/mass spectroscopy. In mice, scratch activity after intradermal pruritogen injection was quantified using a magnetic device.
RESULTS: Transient increases in neuronal [Ca2?]i induced by pruritic PBC and ICP sera were higher than corresponding controls. Lysophosphatidic acid (LPA) could be identified as a major [Ca2?]i agonist in pruritic sera, and LPA concentrations were increased in cholestatic patients with pruritus. LPA injected intradermally into mice induced scratch responses. Autotaxin, the serum enzyme converting lysophosphatidylcholine into LPA, was markedly increased in patients with ICP versus pregnant controls (P ?<.0001) and cholestatic patients with versus without pruritus (P <? .0001). Autotaxin activity correlated with intensity of pruritus (P ?<.0001), which was not the case for serum bile salts, histamine, tryptase, substance P, or ?-opioids. In patients with PBC who underwent temporary nasobiliary drainage, both itch intensity and autotaxin activity markedly decreased during drainage and returned to preexistent levels after drain removal.
CONCLUSIONS: We suggest that LPA and autotaxin play a critical role in cholestatic pruritus and may serve as potential targets for future thera- peutic interventions.
Keywords: Autotaxin; Bile Salts; Cholestasis; Itch.

Oral supplementation with fish oil reduces dryness and pruritus in the acetone-induced dry skin rat model

1-s2.0-S0923181115300207-main

Raquel C.S. Barcelosa,b,c,d,f, Cristina de Mello-Sampayob,c,f,*, Caren T.D. Antoniazzia, Hecson J. Segata, Henrique Silvad, Juliana C. Veite, Jaqueline Piccoloe,
Tatiana Emanuellia,e, Marilise E. Bürgera, Beatriz Silva- Limab,c, Luis M. Rodriguesb,d
a Universidade Federal de Santa Maria (UFSM), Programa de Pós-Graduação em Farmacologia, Santa Maria, RS, Brazil
b Pharmacological Sciences Department, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal
c Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal
d CBIOS, Research Center for Bioscience and Health Technologies, Universidade Lusófona, Lisboa, Portugal
e Departamento de Tecnologia dos Alimentos, Programa de Pós-Graduação em Ciência Tecnologia dos Alimentos, Universidade Federal de Santa Maria, Av. Roraima, 1000, 97105-900 Santa Maria, RS, Brazil
f Both authors have contributed equally to this work.

Background: Pruritus and discomfort are often present in patients with xerosis and atopic dermatitis. Several studies suggest an important role of diet in skin pathophysiology.
Objective: This study evaluated the effect of dietary fatty acids in the skin physiology via an itch-related animal model with and without supplementation with fish oil (FO), a source of polyunsaturated fatty acids (PUFA), especially omega 3 (n-3).
Methods: Male Wistar rats were divided into two groups—non-supplemented (control) and supplemented with FO (3g/kg/day) by gavage for 90 days. Every 30 days, scratching and skin parameters (transepidermal water loss (TEWL), hydration, and local blood flow) were evaluated before and after dorsal skin exposure to acetone to induce the itch-related dry skin. At the end of the study, animals were sacrificed, and skin samples collected for fatty acids composition analysis by GC–FID. Results: FO supplementation reduced the TEWL and increased the skin hydration, with significant changes from day 60 on, while skin microcirculation registered no changes. It also alleviated the acetone induced skin barrier alteration, revealed by a faster resolution of TEWL and hydration, and elimination of itch-related scratching induced by dry skin. These changes were associated with the shift in the skin fatty acids incorporation pattern (richer in n-3 with n-6/n-3 < 5) resulting from the FO supplementation. Conclusion: Skin barrier dynamics seem to be influenced by FO n-3 PUFA, with suppressive effects on the scratching behaviour induced by dry skin. Hence, long-term supplementation with n-3 PUFA rich nutrients might reinforce and restore cutaneous integrity and function.
ã 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Histamine Released from Epidermal Keratinocytes Plays a Role in a-MelanocyteeStimulating Hormone-Induced Itching in Mice

Histamine Released from Epidermal Keratinocytes Plays a Role in α-Melanocyte–Stimulating Hormone-Induced Itching in Mice

Kyoko Shimizu,* Tsugunobu Andoh,y Yoko Yoshihisa,* and Tadamichi Shimizu*
From the Departments of Dermatology* and Applied Pharmacology,y Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
Accepted for publication July 14, 2015.
Address correspondence to Tadamichi Shimizu, Depart- ment of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, Japan. E-mail: shimizut@med.u- toyama.ac.jp.

Sunburn, wound repair, and chronic renal failure with hemodialysis are usually accompanied by both pigmentation and itching. Proopiomelanocortin-derived a-melanocyteestimulating hormone (a-MSH) is produced in response to external stimuli, such as UV irradiation, and is involved in cutaneous pigmen- tation. However, it is unclear whether a-MSH is also involved in the itching. We therefore investigated whether a-MSH elicited itch-related responses in mice. We found that an intradermal injection of a-MSH induced hind-paw scratching, an itch-related response, in mice. The a-MSHeinduced scratching was inhibited by the m-opioid receptor antagonist naltrexone and the H1 histamine receptor antagonist terfenadine. In mast cell-deficient mice, a-MSH also elicited scratching, which was inhibited by terfe- nadine. The immunoreactivity for L-histidine decarboxylase, a key enzyme required for the production of histamine, histamine, and the melanocortin 1 and 5 receptors were shown in not only mast cells but also keratinocytes in murine skin. In addition to the expression of L-histidine decarboxylase and melanocortin 1 and 5 receptors, the mouse keratinocyte cell lines (Pam212) also showed immunoreactivity for L-his- tidine decarboxylase, histamine, and melanocortin 1 and 5 receptors. The application of a-MSH induced the release of histamine from Pam212 cells. These findings indicate that a-MSH may play an important role in the itching associated with pigmented cutaneous lesions and that the histamine released from keratinocytes is involved in this a-MSHeinduced itching. (Am J Pathol 2015, -: 1e8; http://dx.doi.org/ 10.1016/j.ajpath.2015.07.015)

Antipruritic mechanisms of topical E6005, a phosphodiesterase
4 inhibitor: Inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP
Tsugunobu Andoh, Yasushi Kuraishi *
Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan

1-s2.0-S0923181114002497-main

ABSTRACT
Background: Phosphodiesterase 4 (PDE4), which catalyses the conversion of cyclic adenosine 30,50- monophosphate (cAMP) to 50-AMP, plays a critical role in the pathogenesis of inflammatory disorders. Pruritus is the main symptom of dermatitides, such as atopic dermatitis, and is very difficult to control. Recent studies have shown that the activation of proteinase-activated receptor 2 (PAR2) is involved in pruritus in dermatoses in humans and rodents.
Objective: To investigate the inhibitory effect of E6005, a topically effective PDE4 inhibitor, on PAR2-associated itching in mice.
Methods: Mice were given an intradermal injection of SLIGRL-NH2 (100 nmol/site), a PAR2 agonist peptide, into the rostral part of the back. E6005 and 8-bromo-cAMP were applied topically and injected intradermally, respectively, to the same site. Scratching bouts were observed as an itch-related behavior, and firing activity of the cutaneous nerve was electrophysiologically recorded. Keratinocytes were isolated from the skin of neonatal mice and cultured for in vitro experiments. The concentrations of cAMP and leukotriene B4 (LTB4) were measured by enzyme immunoassay. The distribution of PDE4 subtypes in the skin was investigated by immunostaining.
Results: Topical E6005 and intradermal 8-bromo-cAMP significantly inhibited SLIGRL-NH2-induced scratching and cutaneous nerve firing. Topical E6005 increased cutaneous cAMP content. Topical E6005 and intradermal 8-bromo-cAMP inhibited cutaneous LTB4 production induced by SLIGRL-NH2, which has been shown to elicit LTB4-mediated scratching. E6005 and 8-bromo-cAMP inhibited SLIGRL-NH2- induced LTB4 production in the cultured murine keratinocytes also. PDE4 subtypes were mainly expressed in keratinocytes and mast cells in the skin.
Conclusions: The results suggest that topical E6005 treatment inhibits PAR2-associated itching. Inhibition of LTB4 production mediated by an increase in cAMP may be partly involved in the antipruritic action of E6005.
ß 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Redefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of Mrgprs

ncomms8864

Vemuri B. Reddy1,*, Shuohao Sun2,*, Ehsan Azimi1, Sarina B. Elmariah1, Xinzhong Dong2 & Ethan A. Lerner1
Sensory neurons expressing Mas-related G-protein-coupled receptors (Mrgprs) mediate histamine-independent itch. We show that the cysteine protease cathepsin S activates MrgprC11 and evokes receptor-dependent scratching in mice. In contrast to its activation of conventional protease-activated receptors, cathepsin S-mediated activation of MrgprC11 did not involve the generation of a tethered ligand. We demonstrate further that different cysteine proteases selectively activate specific mouse and human Mrgpr family members. This expansion of our understanding by which proteases interact with G-protein-coupled receptors (GPCRs) redefines the concept of what constitutes a protease-activated receptor. The findings also implicate proteases as ligands to members of this orphan receptor family while providing new insights into how cysteine proteases contribute to itch.